Scientific Program Committee

Tuesday
February 5 Sessions
Session 33 CROI 2008
e Tuesday, 4-6 pm; Auditorium
Session 33–Symposium CME
Targeting TB: New Opportunities and Challenges
Conveners:
Richard Chaisson, Johns Hopkins Univ Sch
of Med, Baltimore, MD, US
Betina Durovni, Dept of Publ Hlth, Rio de
Janeiro, Brazil
109
How Can Scientific Advances Contribute to TB
Control
William Bishai
Johns Hopkins Univ Sch of Med, Baltimore, MD, US
110
Prospects for New Drugs for TB
Timothy Sterling
Vanderbilt Univ Sch of Med, Nashville, TN, US
111
Concurrent Management of TB and HIV
Stephen Lawn
Univ of Cape Town, South Africa and London Sch of Hygiene &
Tropical Med, UK
112
Confronting the Catastrophe of M/XDR TB
Gerald Friedland and TF CARES
Yale Univ, New Haven, CT, US
Objectives: This session is directed to clinicians and scientists interested
in controlling TB and TB/HIV co-infection, using new tools and strategies.
It is assumed that participants are familiar with the natural history and
clinical manifestations of TB and TB/HIV, as well as with conventional
treatment paradigms. At the completion of the session, participants with be
knowledgeable about scientific advances in TB genomics, new drugs in the
pipeline for treating and preventing TB, special challenges in co-managing
TB and HIV disease, and the prospects for controlling multi-drug resistance
(MDR) and extremely drug-resistant (XDR) TB.
18 15th Conference on Retroviruses and Opportunistic Infections